Ron Bentsur - Chairman & CEO, Director, 10%+ Owner at Nuvectis Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman & CEO, Director, 10%+ Owner
Stock Symbol
NVCT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Ron Bentsur - trading volume in the past year for Nuvectis Pharma, Inc.

Holdings reported by Ron Bentsur for Nuvectis Pharma, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.25M $21.9M $6.74 May 14, 2024 Direct

Transactions reported by Ron Bentsur for Nuvectis Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.